Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Total Debt Over TimeNormalizing
Percentile Rank33
3Y CAGR-5.9%
5Y CAGR-10.4%
Year-over-Year Change
Sum of short-term and long-term debt obligations
3Y CAGR
-5.9%/yr
Annual compound
5Y CAGR
-10.4%/yr
Recent acceleration
Percentile
P33
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
3 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $39.19M | -8.3% |
| 2024 | $42.72M | -7.2% |
| 2023 | $46.04M | -2.0% |
| 2022 | $47.00M | - |
| 2021 | $0.00 | -100.0% |
| 2020 | $67.76M | +8935.2% |
| 2019 | $750000.00 | - |